David Toung
Stock Analyst at Argus Research
(3.35)
# 1,003
Out of 5,055 analysts
128
Total ratings
64.65%
Success rate
9.79%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $578.71 | +5.41% | 8 | Oct 29, 2025 | |
| HOLX Hologic | Maintains: Buy | $80 → $90 | $74.15 | +21.38% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $95.87 | +19.95% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $237.12 | +18.92% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $325.83 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $33.05 | +57.34% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $321.86 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $11.77 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $232.36 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $205.37 | -39.13% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $167.81 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $336.74 | +0.97% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $842.09 | -20.44% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $89.91 | +66.83% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,025.28 | -18.07% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $73.15 | +50.38% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $266.89 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.06 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $362.22 | -14.42% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $472.65 | -34.41% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $549.51 | -41.77% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $130.59 | +3.38% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $125.02 | -40.01% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $46.65 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $92.92 | +18.38% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.92 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $59.38 | +106.30% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $89.10 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $131.26 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $195.93 | -20.89% | 4 | Mar 27, 2020 |
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $578.71
Upside: +5.41%
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $74.15
Upside: +21.38%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $95.87
Upside: +19.95%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $237.12
Upside: +18.92%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $325.83
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $33.05
Upside: +57.34%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $321.86
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $11.77
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $232.36
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $205.37
Upside: -39.13%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $167.81
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $336.74
Upside: +0.97%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $842.09
Upside: -20.44%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $89.91
Upside: +66.83%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,025.28
Upside: -18.07%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $73.15
Upside: +50.38%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $266.89
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.06
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $362.22
Upside: -14.42%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $472.65
Upside: -34.41%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $549.51
Upside: -41.77%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $130.59
Upside: +3.38%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $125.02
Upside: -40.01%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $46.65
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $92.92
Upside: +18.38%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.92
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $59.38
Upside: +106.30%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $89.10
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $131.26
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $195.93
Upside: -20.89%